Related Experiment Videos
Bone marrow transplantation corrects the splenic reticuloendothelial dysfunction in sickle cell anemia
A Ferster1, W Bujan, F Corazza
1Pediatric Hematology/Oncology Unit, Hôpital Universitaire des Enfants Reine Fabiola, Brussels, Belgium.
Blood
|February 15, 1993
Summary
Bone marrow transplantation (BMT) can restore splenic function in children with severe sickle cell anemia (SCA). This study shows BMT corrects permanent asplenia, a common complication of SCA.
Area of Science:
- Hematology
- Pediatric Medicine
- Transplantation Immunology
Background:
- Sickle cell anemia (SCA) often leads to functional asplenia due to splenic vaso-occlusion.
- Functional asplenia in SCA is typically permanent by late childhood.
- Asplenia increases susceptibility to infections in SCA patients.
Purpose of the Study:
- To evaluate the efficacy of bone marrow transplantation (BMT) in reversing functional asplenia in pediatric SCA patients.
- To assess the restoration of reticuloendothelial splenic function post-BMT.
Main Methods:
- Three pediatric patients with severe SCA and functional asplenia were treated with BMT.
- Pre- and post-BMT assessment included blood smear analysis for Howell-Jolly bodies and technetium 99m (99mTc) splenic uptake scans.
Main Results:
- All patients exhibited Howell-Jolly bodies and absent 99mTc splenic uptake pre-BMT, confirming functional asplenia.
- Post-BMT, Howell-Jolly bodies resolved, and 99mTc scans demonstrated normal splenic uptake.
- BMT successfully restored splenic reticuloendothelial function in all treated patients.
Conclusions:
- Bone marrow transplantation can effectively correct functional asplenia in children with sickle cell anemia.
- BMT offers a potential therapeutic strategy for splenic dysfunction in SCA.
- Further research is needed to determine if BMT addresses other SCA-related organ damage.